- Home
- ORGO vs RPAY Comparison
ORGO vs RPAY Comparison
Compare ORGO & RPAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORGO
- RPAY
- Stock Information
- Founded
- ORGO 1985
- RPAY 2006
- Country
- ORGO United States
- RPAY United States
- Employees
- ORGO N/A
- RPAY N/A
- Industry
- ORGO Biotechnology: Pharmaceutical Preparations
- RPAY Business Services
- Sector
- ORGO Health Care
- RPAY Consumer Discretionary
- Exchange
- ORGO Nasdaq
- RPAY Nasdaq
- Market Cap
- ORGO 384.4M
- RPAY 387.2M
- IPO Year
- ORGO N/A
- RPAY N/A
- Fundamental
- Price
- ORGO $3.46
- RPAY $4.78
- Analyst Decision
- ORGO Buy
- RPAY Buy
- Analyst Count
- ORGO 2
- RPAY 9
- Target Price
- ORGO $5.50
- RPAY $8.06
- AVG Volume (30 Days)
- ORGO 911.8K
- RPAY 1.6M
- Earning Date
- ORGO 08-07-2025
- RPAY 08-07-2025
- Dividend Yield
- ORGO N/A
- RPAY N/A
- EPS Growth
- ORGO N/A
- RPAY N/A
- EPS
- ORGO N/A
- RPAY N/A
- Revenue
- ORGO $458,760,000.00
- RPAY $309,647,000.00
- Revenue This Year
- ORGO $2.62
- RPAY N/A
- Revenue Next Year
- ORGO $12.46
- RPAY $8.28
- P/E Ratio
- ORGO N/A
- RPAY N/A
- Revenue Growth
- ORGO 5.35
- RPAY 2.26
- 52 Week Low
- ORGO $2.28
- RPAY $3.59
- 52 Week High
- ORGO $6.71
- RPAY $10.86
- Technical
- Relative Strength Index (RSI)
- ORGO 54.42
- RPAY 51.96
- Support Level
- ORGO $3.13
- RPAY $4.55
- Resistance Level
- ORGO $3.36
- RPAY $4.74
- Average True Range (ATR)
- ORGO 0.21
- RPAY 0.19
- MACD
- ORGO 0.08
- RPAY -0.05
- Stochastic Oscillator
- ORGO 74.36
- RPAY 29.27
About ORGO Organogenesis Holdings Inc.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.
About RPAY Repay Holdings Corporation
Repay Holdings Corp is engaged in providing integrated payment processing solutions to verticals that have transaction processing needs. It allows customers to pay through Mobile App, Text, Interactive Voice Response, Virtual Terminal, Hosted Payment Page and Online Customer Portal among others. It operates in two segments Consumer Payments and Business Payments.